[go: up one dir, main page]

PE20050496A1 - Peliculas que se disuelven por via oral - Google Patents

Peliculas que se disuelven por via oral

Info

Publication number
PE20050496A1
PE20050496A1 PE2004000696A PE2004000696A PE20050496A1 PE 20050496 A1 PE20050496 A1 PE 20050496A1 PE 2004000696 A PE2004000696 A PE 2004000696A PE 2004000696 A PE2004000696 A PE 2004000696A PE 20050496 A1 PE20050496 A1 PE 20050496A1
Authority
PE
Peru
Prior art keywords
nicotine
nicilotine
poly
mixtures
monohydrate
Prior art date
Application number
PE2004000696A
Other languages
English (en)
Inventor
Shing Yue Chan
Li-Lan Chen
John Jiangnan Liu
Dushendra J Chetty
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34102944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20050496(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE20050496A1 publication Critical patent/PE20050496A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

SE REFIERE A UNA COMPOSICION DE PELICULA, QUE COMPRENDE: a)UN POLIMERO ENTERICO, QUE SE PRENEUTRALIZA Y ES SELECCIONADO DE: ACETATO FTALATO DE CELULOSA, FTALATO DE HIDROXIPROPILMETILCELULOSA, POLI(FTALATO DE VINILACETATO), COPOLIMERO DE POLI(ETILACRILATO-ACIDO METACRILICO), LACA, ACETATO SUCCINATO DE HIDROXIPROPILMETILCELULOSA, ESTER DE MONOETILO DE POLI(METIL-VINIL-ETER/ACIDO MALEICO) Y ESTER DE N-BUTILO DE POLI(METIL-VINIL-ETER/ACIDO MALEICO) Y SUS MEZCLAS; b)AL MENOS UN AGENTE TAMPON ALCALINO, QUE SE SELECCIONA DE CARBONATO DE SODIO, BICARBONATO DE SODIO, CARBONATO DE POTASIO, HIDROXIDO DE ALUMINIO, ENTRE OTROS Y SUS MEZCLAS; c)AL MENOS UN AGENTE ACTIVO, TAL COMO NICOTINA, SELECCIONADO DE MONOTARTRATO DE NICOTINA, BITARTRATO DE NICOTINA, HIDROCLORURO DE NICOTINA, DIHIDROCLORURO DE NICOTINA, SULFATO DE NICOTINA, MONOHIDRATO DE CLORURO DE CINC DE NICOTINA, SALICILATO DE NICOTINA, ACEITE DE NICOTINA, NICOTINA ACOMPLEJADA CON CICLODEXTRINA, RESINAS DE POLIMERO, TALES COMO LA NICOTINA POLACRILEX Y SUS MEZCLAS; Y, d)UN PLASTIFICANTE. LA COMPOSICION DESCRITA SE DISUELVE RAPIDAMENTE PERMITIENDO LA LIBERACION RAPIDA DE UN AGENTE ACTIVO EN LA CAVIDAD BUCAL, SIENDO UTILES EN TERAPIAS DE REEMPLAZO DE NICOTINA, BRINDANDO ALIVIO EN EL ANSIA DE NICOTINA
PE2004000696A 2003-07-24 2004-07-22 Peliculas que se disuelven por via oral PE20050496A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48985503P 2003-07-24 2003-07-24

Publications (1)

Publication Number Publication Date
PE20050496A1 true PE20050496A1 (es) 2005-06-12

Family

ID=34102944

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000696A PE20050496A1 (es) 2003-07-24 2004-07-22 Peliculas que se disuelven por via oral

Country Status (23)

Country Link
US (1) US9675548B2 (es)
EP (2) EP2446881B1 (es)
JP (4) JP2006528636A (es)
CN (1) CN100508976C (es)
AR (1) AR045076A1 (es)
AU (2) AU2004259006B2 (es)
BR (1) BRPI0412752B8 (es)
CA (1) CA2533577C (es)
CL (2) CL2008002407A1 (es)
DK (2) DK1648421T3 (es)
ES (2) ES2654062T3 (es)
HR (1) HRP20171944T1 (es)
HU (1) HUE037508T2 (es)
LT (1) LT1648421T (es)
MX (1) MXPA06000852A (es)
PE (1) PE20050496A1 (es)
PL (2) PL1648421T3 (es)
PT (2) PT2446881E (es)
RU (2) RU2351315C2 (es)
SI (1) SI1648421T1 (es)
TW (1) TW200514579A (es)
UY (1) UY28431A1 (es)
WO (1) WO2005009386A2 (es)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
US7810507B2 (en) 2006-02-10 2010-10-12 R. J. Reynolds Tobacco Company Smokeless tobacco composition
WO2007095600A2 (en) * 2006-02-17 2007-08-23 Novartis Ag Disintegrable oral films
US20100015068A1 (en) * 2006-07-06 2010-01-21 Massachusetts Institute Of Technology Methods and Compositions For Altering Biological Surfaces
WO2008080773A1 (de) * 2006-12-29 2008-07-10 Basf Se Verfahren zur herstellung von festen dosierungsformen enthaltend pfropfcopolymere
FR2912915B1 (fr) * 2007-02-28 2012-11-16 Pf Medicament Film a desintegration rapide pour l'administration buccale de substances actives.
EP2134321A2 (en) * 2007-03-07 2009-12-23 Novartis Ag Orally administrable films
BRPI0721654B8 (pt) * 2007-05-07 2022-07-05 Evonik Roehm Gmbh formas de dosagem sólida compreendendo um revestimento entérico com liberação acelerada do fármaco, seu método de fabricação e uso
DK2377413T3 (en) 2007-07-23 2017-05-01 Reynolds Tobacco Co R Smokeless tobacco compositions and methods of treating tobacco for use therein
WO2009043588A2 (en) * 2007-10-02 2009-04-09 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Ph regulating antibacterial films for the oral or vaginal cavity
US9125434B2 (en) 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
MY185299A (en) * 2007-10-11 2021-04-30 Philip Morris Products Sa Smokeless tobacco product
JP2009102287A (ja) * 2007-10-19 2009-05-14 Seiji Sakao 禁煙用の辛い唐辛子
WO2009073190A1 (en) * 2007-12-04 2009-06-11 Swedish Match North America, Inc. Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
WO2009080021A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
EP2229158B1 (en) * 2007-12-20 2016-08-10 Fertin Pharma A/S Compressed chewing gum tablet
WO2009099830A2 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips for immediate release of active ingredients
CA2711974A1 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips with modified release active ingredients
EA018330B1 (ru) * 2008-02-13 2013-07-30 Байер Интеллекчуал Проперти Гмбх Система доставки лекарственного средства со стабилизирующим эффектом
CN102006863A (zh) * 2008-04-15 2011-04-06 盐野义制药株式会社 膜组合物
RU2739302C2 (ru) * 2008-11-13 2020-12-22 Ногра Фарма Лимитед Антисмысловые композиции и способы их получения и применения
EP2210595A1 (en) * 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
US20100256215A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Menthol-Melatonin Dissolving Film
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
JP2012526815A (ja) * 2009-05-12 2012-11-01 ビーピーエスアイ ホールディングス， エルエルシー 高防湿即時放出フィルムコーティングシステム、及びこれによってコーティングされた基材
US9017718B2 (en) * 2009-05-21 2015-04-28 Bionex Pharmaceuticals Llc Dual and single layer dosage forms
US8944072B2 (en) 2009-06-02 2015-02-03 R.J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US8434496B2 (en) 2009-06-02 2013-05-07 R. J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
CN102480958B (zh) 2009-06-12 2015-08-19 Cynapsus疗法有限公司 舌下阿扑吗啡
WO2010146601A1 (en) * 2009-06-15 2010-12-23 Unijules Life Sciences Ltd Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents
US20110220130A1 (en) 2009-12-15 2011-09-15 John-Paul Mua Tobacco Product And Method For Manufacture
US20110139164A1 (en) * 2009-12-15 2011-06-16 R. J. Reynolds Tobacco Company Tobacco Product And Method For Manufacture
US8955523B2 (en) 2010-01-15 2015-02-17 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
US20130014771A1 (en) 2011-01-13 2013-01-17 R. J. Reynolds Tobacco Company Tobacco-derived components and materials
US8397945B2 (en) 2010-02-23 2013-03-19 R.J. Reynolds Tobacco Company Dispensing container
CN103025321A (zh) * 2010-03-23 2013-04-03 生物联合制药公司 快速溶解的药物释放系统
US9039839B2 (en) 2010-04-08 2015-05-26 R.J. Reynolds Tobacco Company Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material
EP2557947A1 (en) 2010-04-14 2013-02-20 Altria Client Services Inc. Preformed smokeless tobacco product
US9402415B2 (en) 2010-04-21 2016-08-02 R. J. Reynolds Tobacco Company Tobacco seed-derived components and materials
CN102858327A (zh) * 2010-04-27 2013-01-02 诺瓦提斯公司 口腔剂型
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US9675102B2 (en) 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
DE102010048408A1 (de) 2010-10-15 2012-04-19 Lts Lohmann Therapie-Systeme Ag Laminat mit verbessertem Wasserretentionsverhalten
US20120125354A1 (en) 2010-11-18 2012-05-24 R.J. Reynolds Tobacco Company Fire-Cured Tobacco Extract and Tobacco Products Made Therefrom
KR101946774B1 (ko) 2010-12-16 2019-02-11 선오비온 파마슈티컬스 인코포레이티드 설하 필름
US20120152265A1 (en) 2010-12-17 2012-06-21 R.J. Reynolds Tobacco Company Tobacco-Derived Syrup Composition
US9107453B2 (en) 2011-01-28 2015-08-18 R.J. Reynolds Tobacco Company Tobacco-derived casing composition
US8893725B2 (en) 2011-01-28 2014-11-25 R. J. Reynolds Tobacco Company Polymeric materials derived from tobacco
US9254001B2 (en) 2011-04-27 2016-02-09 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
US9192193B2 (en) 2011-05-19 2015-11-24 R.J. Reynolds Tobacco Company Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
EP3108876A1 (en) * 2011-10-13 2016-12-28 Jaleva Pharmaceuticals LLC Methods and compositions for rapid transbuccal delivery of active agents
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130125907A1 (en) 2011-11-17 2013-05-23 Michael Francis Dube Method for Producing Triethyl Citrate from Tobacco
US10881132B2 (en) 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
EP2827727B1 (en) 2012-03-19 2021-10-13 R. J. Reynolds Tobacco Company Method for treating an extracted tobacco pulp and tobacco products made therefrom
US10799451B2 (en) * 2012-03-27 2020-10-13 Nicoccino Ab Nicotine formulation
EP2874824B1 (en) 2012-07-23 2025-04-30 Crayola, LLC Dissolvable films and methods of using the same
EP2906210A4 (en) * 2012-10-12 2016-06-08 Jaleva Pharmaceuticals Llc METHOD FOR PRODUCING RESIN TINCTURES
EP2925273A4 (en) 2012-11-28 2016-08-31 Jaleva Pharmaceuticals Llc DOPPELKAMMERAPPLIKATOR
US20140166028A1 (en) * 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit
US20140166027A1 (en) * 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit
US9289011B2 (en) 2013-03-07 2016-03-22 R.J. Reynolds Tobacco Company Method for producing lutein from tobacco
US9420827B2 (en) * 2013-03-14 2016-08-23 Altria Client Services Llc Soft oral product
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
US20140275148A1 (en) * 2013-03-15 2014-09-18 Novus Pharma LLC Orally administrable, self-supporting dissolving film dosage forms
US20160101108A1 (en) * 2013-05-23 2016-04-14 Åbo Akademi University Printed dosage forms
US20150034109A1 (en) 2013-08-02 2015-02-05 R.J. Reynolds Tobacco Company Process for Producing Lignin from Tobacco
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
RU2646501C2 (ru) * 2013-09-11 2018-03-05 3М Инновейтив Пропертиз Компани Композиции для полости рта
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US20150147555A1 (en) * 2013-11-23 2015-05-28 Orahealth Corporation Multilayer mucoadhering patch with a nonadhering layer comprising casein
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
KR102396906B1 (ko) 2013-12-31 2022-05-13 존슨 앤드 존슨 컨수머 인코포레이티드 다층의 형상화된 필름을 형성하기 위한 방법
ES2977380T3 (es) 2013-12-31 2024-08-22 Johnson & Johnson Consumer Inc Proceso para formar un producto de película conformado
AU2014374017B2 (en) 2013-12-31 2018-09-13 Kenvue Brands Llc Single-pass process for forming a multilayered shaped film product
US9265284B2 (en) 2014-01-17 2016-02-23 R.J. Reynolds Tobacco Company Process for producing flavorants and related materials
KR20170117374A (ko) * 2014-12-09 2017-10-23 모노졸 알엑스, 엘엘씨 선형 다당류-기반 필름 생성물
DE102015201871B4 (de) * 2015-02-03 2018-04-05 Ferton Holding S.A. Verwendung eines Pulvers als Mittel zur Pulverstrahlbearbeitung in einem Pulverstrahlgerät und Verfahren zur Reinigung von Zähnen
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法
US20170059554A1 (en) 2015-09-02 2017-03-02 R. J. Reynolds Tobacco Company Method for monitoring use of a tobacco product
ITUB20153446A1 (it) * 2015-09-07 2017-03-07 Pharmafilm Srl Film orodispersibili a rapida disgregazione per uso terapeutico o alimentare
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
US11154087B2 (en) 2016-02-02 2021-10-26 R.J. Reynolds Tobacco Company Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds
CN109475508A (zh) * 2016-06-07 2019-03-15 阿瑞迪思医药品股份有限责任公司 具有增强的热稳定性的含有生物活性材料的速溶薄膜的制备方法
IL247161A0 (en) * 2016-08-08 2016-12-29 Rubin Yoram Fast-dissolving adhesive films for the treatment of oral conditions
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
CA3062704A1 (en) * 2017-05-08 2018-11-15 Intelgenx Corp. Film dosage form with extended release mucoadhesive particles
PL3720418T3 (pl) 2017-12-08 2021-12-20 Fertin Pharma A/S Tabletka nikotynowa
CA3085065C (en) 2017-12-08 2023-12-05 Fertin Pharma A/S Formulations providing high nicotine concentrations
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
US11612564B2 (en) * 2018-04-21 2023-03-28 Quest Products, Llc Bilayer adhering lozenge effective to mask undesirable flavor
EP3807260B1 (en) 2018-06-15 2024-09-18 R. J. Reynolds Tobacco Company Purification of nicotine
WO2019244176A1 (en) * 2018-06-23 2019-12-26 Strides Shasun Limited Stable nicotine lozenges
US11235013B2 (en) 2018-09-04 2022-02-01 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
DE102019135432A1 (de) * 2019-12-20 2021-06-24 Lts Lohmann Therapie-Systeme Ag Lösliche Rückschicht für OTF
WO2021177941A1 (en) * 2020-03-03 2021-09-10 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
US20220346436A1 (en) * 2021-04-22 2022-11-03 Nicoventures Trading Limited Orally dissolving films
WO2024201504A1 (en) * 2023-03-25 2024-10-03 Sri Ramachandra Institute Of Higher Education & Research A process of preparation of fast dispersing film containing ascorbic acid and product thereof
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物
CN116570027A (zh) * 2023-06-15 2023-08-11 东莞市吉纯生物技术有限公司 一种含有辣椒素提取物的口含制品及其制备方法
WO2025043236A1 (en) * 2023-08-24 2025-02-27 Joseph Fuisz Edible oral films, compositions, method of manufacture and packaging systems
CN117883415A (zh) * 2023-12-12 2024-04-16 深圳华宝协同创新技术研究院有限公司 一种尼古丁均衡释放口腔膜及其制备方法

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288498A (en) 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
JPH0729915B2 (ja) * 1986-02-01 1995-04-05 帝國製薬株式会社 シ−ト状口腔内貼付剤
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
DE3827561C1 (es) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JPH09505028A (ja) * 1993-07-09 1997-05-20 シグナス，インコーポレイテッド 経皮的／経頬的にニコチン置換治療を提供する方法およびデバイス
SG93789A1 (en) 1994-03-16 2003-01-21 Xaar Ltd Improvements relating to pulsed droplet deposition apparatus
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
AU4657896A (en) 1995-01-19 1996-08-07 Cygnus, Inc. Polyisobutylene adhesives containing high TG tackifier for transdermal devices
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
CZ298212B6 (cs) 1996-05-13 2007-07-25 Novartis Consumer Health S. A. Pomalu se rozpadající pastilka
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
DE19626045C2 (de) * 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
USRE38524E1 (en) * 1997-06-25 2004-06-01 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US20030176467A1 (en) 1997-09-25 2003-09-18 Sven Andersson Nicotine compositions
SE9703458D0 (sv) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
JP3460538B2 (ja) 1997-10-08 2003-10-27 救急薬品工業株式会社 速溶性フィルム製剤
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
ES2310636T3 (es) * 1998-06-18 2009-01-16 F. Hoffmann-La Roche Ag Proceso para sulfuros de arilalquilo.
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
ES2237415T5 (es) * 1999-01-14 2008-12-16 Noven Pharmaceuticals, Inc. Composiciones dermicas.
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
JP4555436B2 (ja) 2000-06-29 2010-09-29 富士通株式会社 薄膜樹脂基板への樹脂モールド方法及び高周波モジュール
DE10032456A1 (de) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
WO2002042981A1 (en) * 2000-11-22 2002-05-30 Ausubel Lawrence M System and method for a dynamic auction with package bidding
US20020131990A1 (en) 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
DE10110391A1 (de) * 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
AR033444A1 (es) * 2001-03-26 2003-12-17 Smithkline Beecham Corp Forma solida de dosificacion util para la administracion oral de un compuesto activo de nicotina, a traves de la mucosa y uso de un compuesto activo de nicotina para prepararla
CA2449415A1 (en) * 2001-04-20 2002-10-31 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
JP2004534822A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 低溶解度および／または酸感受性の薬剤と中和された酸性ポリマーとを含む医薬組成物
WO2003003957A1 (en) * 2001-07-06 2003-01-16 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US20030092724A1 (en) * 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
MXPA04002992A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Composicion comestible y forma de dosificacion que comprende una cubierta comestible.
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
CA2411889A1 (en) 2001-11-16 2003-05-16 National Starch And Chemical Investment Holding Corporation Films containing starch
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch
JP4999037B2 (ja) * 2001-11-23 2012-08-15 ワーナー チルコット カンパニー リミテッド ライアビリティ カンパニー 複数のコーティングを有する医薬剤形
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
US20040013752A1 (en) * 2002-07-05 2004-01-22 Wolfson Philip E. Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
DE10256775A1 (de) 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Filmförmige Zubereitungen zur transmucosalen Verabreichung von Nicotin, sowie Verfahren zu deren Herstellung
ES2708552T3 (es) * 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
US20040208931A1 (en) * 2002-12-30 2004-10-21 Friend David R Fast dissolving films for oral administration of drugs
EP1648362A4 (en) * 2003-07-01 2012-01-11 Todd Maibach THERAPEUTIC AGENTS WITH FILM
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen
KR20050048056A (ko) 2003-11-18 2005-05-24 (주)케이비피 경구용 소모 필름 조성물
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
WO2005115336A2 (en) * 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
EP2457580A1 (en) * 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
ES2596809T3 (es) * 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
JP2008516942A (ja) * 2004-10-15 2008-05-22 ファイザー・プロダクツ・インク バレニクリンの鼻腔内、バッカル、舌下および肺送達のための組成物および方法
GB0508306D0 (en) 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
WO2007095600A2 (en) * 2006-02-17 2007-08-23 Novartis Ag Disintegrable oral films
US20070269386A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
FR2912915B1 (fr) 2007-02-28 2012-11-16 Pf Medicament Film a desintegration rapide pour l'administration buccale de substances actives.
EP2134321A2 (en) 2007-03-07 2009-12-23 Novartis Ag Orally administrable films
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
KR101405930B1 (ko) * 2007-07-05 2014-06-12 엘지전자 주식회사 식기 세척기의 제어방법
US20090081294A1 (en) * 2007-09-26 2009-03-26 Gin Jerry B Sustained release dosage form for lubricating an oral cavity
WO2009045022A2 (en) 2007-10-03 2009-04-09 C.L. Pharm Edible film
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
WO2009073190A1 (en) 2007-12-04 2009-06-11 Swedish Match North America, Inc. Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
JP2012505878A (ja) 2008-10-14 2012-03-08 マクニール アーベー 複数部分口内剤形及びその使用
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20130011462A1 (en) * 2009-12-30 2013-01-10 Novartis Ag Melt extruded nicotine thin strips
CN102858327A (zh) * 2010-04-27 2013-01-02 诺瓦提斯公司 口腔剂型
MX2013003306A (es) 2010-09-24 2013-07-29 Univ Rutgers Sistema y composiciones mejorados para la administracion transbucal de farmacos.

Also Published As

Publication number Publication date
HUE037508T2 (hu) 2018-09-28
JP5572133B2 (ja) 2014-08-13
PT2446881E (pt) 2014-06-11
WO2005009386A2 (en) 2005-02-03
RU2351315C2 (ru) 2009-04-10
AU2004259006A1 (en) 2005-02-03
EP1648421A4 (en) 2009-08-26
ES2654062T3 (es) 2018-02-12
BRPI0412752B8 (pt) 2021-05-25
US20060198873A1 (en) 2006-09-07
JP2010120975A (ja) 2010-06-03
CA2533577A1 (en) 2005-02-03
JP2011225620A (ja) 2011-11-10
JP2011037879A (ja) 2011-02-24
PT1648421T (pt) 2017-12-22
JP5378270B2 (ja) 2013-12-25
US9675548B2 (en) 2017-06-13
EP2446881B1 (en) 2014-04-09
EP1648421A2 (en) 2006-04-26
CL2008002406A1 (es) 2009-01-02
CA2533577C (en) 2014-10-21
RU2006105630A (ru) 2006-07-10
TW200514579A (en) 2005-05-01
ES2466943T3 (es) 2014-06-11
DK1648421T3 (en) 2017-12-04
WO2005009386A3 (en) 2005-09-09
BRPI0412752B1 (pt) 2018-07-10
AR045076A1 (es) 2005-10-12
RU2008101513A (ru) 2009-07-20
CN1826117A (zh) 2006-08-30
EP1648421B1 (en) 2017-10-18
BRPI0412752A (pt) 2006-09-26
MXPA06000852A (es) 2006-03-30
LT1648421T (lt) 2018-01-25
PL1648421T3 (pl) 2018-03-30
AU2010224456B2 (en) 2013-08-29
JP2006528636A (ja) 2006-12-21
CL2008002407A1 (es) 2009-01-02
AU2004259006B2 (en) 2010-10-07
AU2010224456B9 (en) 2013-10-24
HK1169802A1 (en) 2013-02-08
CN100508976C (zh) 2009-07-08
PL2446881T3 (pl) 2014-08-29
DK2446881T3 (da) 2014-06-02
AU2010224456A1 (en) 2010-10-21
HRP20171944T1 (hr) 2018-01-26
JP5038477B2 (ja) 2012-10-03
EP2446881A1 (en) 2012-05-02
SI1648421T1 (en) 2018-02-28
UY28431A1 (es) 2005-02-28

Similar Documents

Publication Publication Date Title
PE20050496A1 (es) Peliculas que se disuelven por via oral
PE20001058A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
JP2006516032A5 (es)
PE20050379A1 (es) Peliculas consumibles por via oral que se disuelven rapidamente que contienen un edulcorante
AR071366A1 (es) Composiciones que comprenden drogas debilmente basicas y formas de dosificacion de liberacion controlada. metodo de preparacion.
ES2414859T3 (es) Bolsa multicompartimental
ES2606342T3 (es) Composiciones para el cuidado bucal de sal estannosa y tripoli-fosfato de sodio y métodos
PE20061160A1 (es) Sistema de administracion de farmacos con retencion gastrica
AR084610A1 (es) Comprimido de desintegracion oral de lansoprazol
PE20050584A1 (es) Composicion y metodo para mejorar la biodisponibilidad
JP2013529072A5 (es)
UY29890A1 (es) Composiciones farmacéuticas sólidas que contienen pregabalina
AR078970A1 (es) Composiciones blanqueadoras de capas solidas y metodos de uso
PE20011122A1 (es) DERIVADOS DE PURINA-2-ILCARBOXAMIDA COMO AGONISTAS SELECTIVOS DEL RECEPTOR A2a DE LA ADENOSINA
JP2010510814A5 (es)
CA2323102A1 (en) Monolithic tablet for controlled drug release
ES2531011T3 (es) Métodos y composiciones para el tratamiento del virus de la hepatitis C
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
MY150626A (en) Fast dissolving solid dosage form
AR044142A1 (es) Formulacion farmaceutica de la sal sodica del telmisartan
CR6740A (es) Peliculas oralmente consumibles de disolucion rapida que contienen una resina de intercambio ionico como un agente disimulante del sabor
JP2018021007A5 (es)
PE20040499A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
AR039955A1 (es) Preparados con principio activo en forma de pelicula con mejora de la estabilidad quimica, y procedimiento para su fabricacion
PE20010303A1 (es) Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido

Legal Events

Date Code Title Description
FG Grant, registration